


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.43%
-6.89%
+4.47%
-2.84%
GILD
Gilead Sciences
$121.26
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market
GILD Price Performance
$118.84 (+2.04%)
$117.86 (+2.88%)
$109.85 (+10.39%)
$90.69 (+33.71%)
GILD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

GILD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
GILD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
GILD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is GILD current stock price?
What are GILD stock strengths?
What is GILD Risk Level?
What is GILD market cap and volume?
What is GILD current Stock IQ?
Should I buy GILD stock right now?
Is GILD a Strong Buy right now?
What does a 'Strong Buy' rating mean for GILD?
What does a 'Strong Sell' rating mean for GILD?
What factors influence GILD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.43%
-6.89%
+4.47%
-2.84%
GILD
Gilead Sciences
Current Price
$121.26
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market

GILD Price Performance
$118.84 (+2.04%)
$117.86 (+2.88%)
$109.85 (+10.39%)
$90.69 (+33.71%)
GILD Analysts Opinion
GILD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
GILD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
GILD Street Sentiment is extremely bullish and have positive views on the near-term outlook
GILD has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
GILD Stock IQ
GILD Latest Analysis
Gilead Sciences Inc. (GILD) Presents at Evercore 8th Annual Healthcare Conference Transcript.
Wed Dec 3, 2025
Gilead Sciences Inc. (GILD) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.
Wed Dec 3, 2025
Insider Activity Update: Jeffrey Bluestone Executes Options Exercise Resulting In $296K At Gilead Sciences. Disclosed in a recent SEC filing on December 1 Bluestone Board Member at GILD) made a noteworthy transaction involving the exercise of company stock options.United States Securities and Exchange Commission Bluestone Board Member at Gilead Sciences exercised stock options for 5000 shares of GILD. The transaction value amounted to $296250.Currently Gilead Sciences develops and markets therap
Tue Dec 2, 2025
Heres How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today. Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 3.09% on an annualized basis producing an average annual return of 11.88%. Currently Gilead Sciences has a market capitalization of $156.02 billion.
Fri Nov 28, 2025
Why Gilead Sciences (GILD) is a Top Momentum Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Fri Nov 28, 2025
Gilead Sciences stock rating reiterated at Outperform by BMO Capital.
Tue Nov 25, 2025
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mon Nov 24, 2025
Gilead Sciences: Rating Upgrade Warranted On HIV Division Strength.
Thu Nov 20, 2025
$1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth This Much Today. Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 5 years by 3.03% on an annualized basis producing an average annual return of 16.24%. Currently Gilead Sciences has a market capitalization of $159.56 billion.
Thu Nov 20, 2025
Gilead Sciences Inc. (GILD) Presents at Jefferies London Healthcare Conference 2025 Transcript.
Wed Nov 19, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GILD Stock trends
GILD Stock performance
GILD Stock analysis
GILD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.